Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT).
Birnie D, Beanlands RSB, Nery P, Aaron SD, Culver DA, DeKemp RA, Gula L, Ha A, Healey JS, Inoue Y, Judson MA, Juneau D, Kusano K, Quinn R, Rivard L, Toma M, Varnava A, Wells G, Wickremasinghe M, Kron J. Birnie D, et al. Among authors: rivard l. Am Heart J. 2020 Feb;220:246-252. doi: 10.1016/j.ahj.2019.10.003. Epub 2019 Oct 20. Am Heart J. 2020. PMID: 31911261 Free PMC article.
Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF-CHF studies.
Tremblay-Gravel M, Khairy P, Roy D, Leduc H, Wyse DG, Cadrin-Tourigny J, Macle L, Dubuc M, Andrade J, Rivard L, Guerra PG, Thibault B, Ahmed A, Talajic M, Guertin MC, White M. Tremblay-Gravel M, et al. Among authors: rivard l. Eur J Heart Fail. 2014 Nov;16(11):1168-74. doi: 10.1002/ejhf.168. Epub 2014 Oct 9. Eur J Heart Fail. 2014. PMID: 25296634 Free article.
Very Low Ventricular Pacing Rates Can Be Achieved Safely in a Heterogeneous Pacemaker Population and Provide Clinical Benefits: The CANadian Multi-Centre Randomised Study-Spontaneous AtrioVEntricular Conduction pReservation (CAN-SAVE R) Trial.
Thibault B, Ducharme A, Baranchuk A, Dubuc M, Dyrda K, Guerra PG, Macle L, Mondésert B, Rivard L, Roy D, Talajic M, Andrade J, Nitzsché R, Khairy P; CAN‐SAVE R Study Investigators. Thibault B, et al. Among authors: rivard l. J Am Heart Assoc. 2015 Jul 23;4(7):e001983. doi: 10.1161/JAHA.115.001983. J Am Heart Assoc. 2015. PMID: 26206737 Free PMC article. Clinical Trial.
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, Thibault B, Rivard L, Gula L, Leong-Sit P, Essebag V, Nery PB, Tung SK, Raymond JM, Sterns LD, Veenhuyzen GD, Healey JS, Redfearn D, Roux JF, Tang AS. Sapp JL, et al. Among authors: rivard l. N Engl J Med. 2016 Jul 14;375(2):111-21. doi: 10.1056/NEJMoa1513614. Epub 2016 May 5. N Engl J Med. 2016. PMID: 27149033 Free article. Clinical Trial.
Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
Cadrin-Tourigny J, Shohoudi A, Roy D, Talajic M, Tadros R, Mondésert B, Dyrda K, Rivard L, Andrade JG, Macle L, Guerra PG, Thibault B, Dubuc M, Khairy P. Cadrin-Tourigny J, et al. Among authors: rivard l. JACC Heart Fail. 2017 Feb;5(2):99-106. doi: 10.1016/j.jchf.2016.10.015. Epub 2017 Jan 11. JACC Heart Fail. 2017. PMID: 28089316 Free article.
Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]).
Parkash R, Wells GA, Sapp JL, Healey JS, Tardif JC, Greiss I, Rivard L, Roux JF, Gula L, Nault I, Novak P, Birnie D, Ha A, Wilton SB, Mangat I, Gray C, Gardner M, Tang ASL. Parkash R, et al. Among authors: rivard l. Circulation. 2017 May 9;135(19):1788-1798. doi: 10.1161/CIRCULATIONAHA.116.026230. Epub 2017 Feb 22. Circulation. 2017. PMID: 28228428 Clinical Trial.
Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
Parkash R, Nault I, Rivard L, Gula L, Essebag V, Nery P, Tung S, Raymond JM, Sterns L, Doucette S, Wells G, Tang ASL, Stevenson WG, Sapp JL. Parkash R, et al. Among authors: rivard l. Circ Arrhythm Electrophysiol. 2018 Jan;11(1):e005663. doi: 10.1161/CIRCEP.117.005663. Circ Arrhythm Electrophysiol. 2018. PMID: 29305400 Clinical Trial.
Mexiletine or catheter ablation after amiodarone failure in the VANISH trial.
Deyell MW, Steinberg C, Doucette S, Parkash R, Nault I, Gray C, Essebag V, Gardner M, Sterns LD, Healey JS, Hruczkowski T, Rivard L, Leong-Sit P, Nery PB, Sapp JL. Deyell MW, et al. Among authors: rivard l. J Cardiovasc Electrophysiol. 2018 Apr;29(4):603-608. doi: 10.1111/jce.13431. Epub 2018 Feb 1. J Cardiovasc Electrophysiol. 2018. PMID: 29356207 Clinical Trial.
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial.
Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L, Leong-Sit P, Novak P, Badra-Verdu M, Sapp J, Mangat I, Khoo C, Steinberg C, Bennett MT, Tang ASL, Khairy P; CIRCA-DOSE Study Investigators. Andrade JG, et al. Circulation. 2019 Nov 26;140(22):1779-1788. doi: 10.1161/CIRCULATIONAHA.119.042622. Epub 2019 Oct 21. Circulation. 2019. PMID: 31630538 Clinical Trial.
181 results